Lobbyist · LDA.gov number 142802

MARGARET MARTIN

11 reportsConfirmed from the official record

MARGARET MARTIN is named as a lobbyist in 11 lobbying reports we hold, filed by 1 registrant for 11 clients.

Every lobbyist

Earlier government jobs, as reported

A lobbying report lists each lobbyist's covered positions: jobs in Congress or the executive branch that the law asks a lobbyist to disclose. Each line is copied as a report states it.

No report we hold lists a covered position for MARGARET MARTIN.

Registrants and clients

Clients: ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED); AVALYN PHARMA INC.; BIOGEN, INC.; BIONJ, INC.; BIOTECHNOLOGY INNOVATION ORGANIZATION; COALITION FOR SMARTER REGULATION OF NICOTINE; IRA WATCHDOG; NOVARTIS; PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA; PRELUDE CORPORATION (PRELUDEDX); REGENXBIO INC..

Bills named where this lobbyist is listed, and how the House and the Senate voted

4 bills named in these reports. None of them became law in our record, so no recorded vote is shown. A lobbying report names the houses of Congress and the agencies the lobbyists contacted. It does not say which members or staff they met.

Bills named in reports that list MARGARET MARTIN
BillStatusHow the House and the Senate voted
H.R. 1492To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.IntroducedNo recorded vote in our record
H.R. 1672Maintaining Investments in New Innovation ActIntroducedNo recorded vote in our record
H.R. 8646Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027Passed the HouseNo recorded vote in our record
S. 832EPIC Act of 2025IntroducedNo recorded vote in our record

Issues named: Health Issues (9), Medicare/Medicaid (6), Medical/Disease Research/Clinical Labs (5), Copyright/Patent/Trademark (3), Pharmacy (3), Trade (domestic/foreign) (3), Budget/Appropriations (1), Defense (1).

Every report

Lobbying reports that name MARGARET MARTIN
ClientRegistrantKind, as filedPostedReport
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICACopyright/Patent/Trademark, Budget/Appropriations, Defense, Trade (domestic/foreign), Pharmacy, Health IssuesDLA PIPER LLP (US)2nd Quarter - ReportThe report on LDA.gov
NOVARTISCopyright/Patent/Trademark, Trade (domestic/foreign), Health Issues, Medicare/MedicaidDLA PIPER LLP (US)2nd Quarter - ReportThe report on LDA.gov
BIOGEN, INC.Pharmacy, Copyright/Patent/Trademark, Health Issues, Medical/Disease Research/Clinical Labs, Trade (domestic/foreign)DLA PIPER LLP (US)2nd Quarter - ReportThe report on LDA.gov
PRELUDE CORPORATION (PRELUDEDX)Health Issues, Medicare/MedicaidDLA PIPER LLP (US)2nd Quarter - ReportThe report on LDA.gov
IRA WATCHDOGMedicare/MedicaidDLA PIPER LLP (US)2nd Quarter - ReportThe report on LDA.gov
COALITION FOR SMARTER REGULATION OF NICOTINEHealth IssuesDLA PIPER LLP (US)2nd Quarter - ReportThe report on LDA.gov
BIONJ, INC.Health IssuesDLA PIPER LLP (US)2nd Quarter - ReportThe report on LDA.gov
ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED)Medicare/Medicaid, Medical/Disease Research/Clinical LabsDLA PIPER LLP (US)2nd Quarter - ReportThe report on LDA.gov
BIOTECHNOLOGY INNOVATION ORGANIZATIONMedical/Disease Research/Clinical Labs, Health Issues, Medicare/Medicaid, PharmacyDLA PIPER LLP (US)2nd Quarter - ReportThe report on LDA.gov
REGENXBIO INC.Health Issues, Medical/Disease Research/Clinical LabsDLA PIPER LLP (US)2nd Quarter - ReportThe report on LDA.gov
AVALYN PHARMA INC.Medical/Disease Research/Clinical Labs, Health IssuesDLA PIPER LLP (US)2nd Quarter - ReportThe report on LDA.gov

Campaign gifts this lobbyist reported

Lobbyists and registrants report their political contributions twice a year (form LD-203). We hold these reports only for contributions to the campaign committees of members who sponsored or cosponsored a bill named in a lobbying report. Any other contribution: Not checked yet.

No contribution report we hold lists a gift from this filer.

Where this comes from

Lobbying Disclosure Act reports (LD-2), LDA.gov. We save our own copy of each page of LDA.gov's list of reports before we read it. These pages were built from our copies on .

2026-Q2: every page of LDA.gov's list saved and read.

A lobbying report states the registrant's income from the client (a lobbying firm) or its own lobbying expenses (an organization lobbying for itself), for the whole quarter and every issue together. A report of less than $5,000, or of no lobbying activity, states no figure. It is not the amount spent on one bill.

Senate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.

Suggest a tool

Suggest a tool

A person reads each idea before it appears. Links are not accepted. Do not include personal information.

See all ideas and vote